BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 27066875)

  • 1. Concurrent ovarian hyperstimulation syndrome with perforated appendicitis following induction ovulation with HMG and HCG.
    Bouzari Z; Yazdani S; Sadeghi T
    Am J Emerg Med; 2016 Oct; 34(10):2051.e5-2051.e6. PubMed ID: 27066875
    [No Abstract]   [Full Text] [Related]  

  • 2. [Ovarian hyperstimulation and its prevention].
    Dumont M
    Nouv Presse Med; 1981 Apr; 10(15):1185-7. PubMed ID: 6784104
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevention and treatment of ovarian hyperstimulation.
    Schenker JG
    Hum Reprod; 1993 May; 8(5):653-9. PubMed ID: 8314955
    [No Abstract]   [Full Text] [Related]  

  • 4. Ovarian hyperstimulation syndrome due to exogenous gonadotropin administration.
    Bider D; Menashe Y; Oelsner G; Serr DM; Mashiach S; Ben-Rafael Z
    Acta Obstet Gynecol Scand; 1989; 68(6):511-4. PubMed ID: 2520805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian hyperstimulation syndrome.
    Williamson K; Mushambi MC
    Br J Anaesth; 1994 Dec; 73(6):731-3. PubMed ID: 7880654
    [No Abstract]   [Full Text] [Related]  

  • 6. Induction of ovulation with combined human gonadotropins and dexamethasone in women with polycystic ovarian disease.
    Evron S; Navot D; Laufer N; Diamant YZ
    Fertil Steril; 1983 Aug; 40(2):183-6. PubMed ID: 6409672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of ovarian hyperstimulation syndrome: novel strategies.
    Grudzinskas JG; Egbase PE
    Hum Reprod; 1998 Aug; 13(8):2051-3. PubMed ID: 9756266
    [No Abstract]   [Full Text] [Related]  

  • 8. [Ovarian hyperstimulation syndrome--a risk of treatment for infertility].
    Bangsbøll S
    Nord Med; 1997 Sep; 112(7):236-9. PubMed ID: 9380489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of human menopausal gonadotropin dose before coasting prevents severe ovarian hyperstimulation syndrome with minimal cycle cancellation.
    Aboulghar MA; Mansour RT; Serour GI; Rhodes CA; Amin YM
    J Assist Reprod Genet; 2000 May; 17(5):298-301. PubMed ID: 10976419
    [No Abstract]   [Full Text] [Related]  

  • 10. [Efficacy of simultaneous use of cryopreserved semen, controlled ovarian hyperstimulation and intrauterine insemination in the treatment of sterility caused by hypergonadotropic azoospermia].
    Kably Ambe A; Góngora Rodríguez A; Barrón Vallejo J; Olgúin Godínez A
    Ginecol Obstet Mex; 1999 Feb; 67():53-7. PubMed ID: 10327765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe ovarian hyperstimulation syndrome (OHSS) and icterus.
    Nawroth F; Heinrich J; Bruns U; Wood WG
    Hum Reprod; 1996 Nov; 11(11):2441-2. PubMed ID: 8981129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of overstimulated gonadotrophin cycles with a controlled drift period.
    Urman B; Pride SM; Yuen BH
    Hum Reprod; 1992 Feb; 7(2):213-7. PubMed ID: 1577933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukocyte behaviour and permeability in the rat mesenteric microcirculation following induction of ovulation.
    Katayama T; Kusanagi Y; Kiyomura M; Ochi H; Ito M
    Hum Reprod; 2003 Jun; 18(6):1179-84. PubMed ID: 12773443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovarian hyperstimulation syndrome: distinction between local and systemic disease.
    Cobellis L; Pecori E; Stradella L; De Lucia E; Messalli EM; Cobellis G
    Gynecol Endocrinol; 2003 Apr; 17(2):95-9. PubMed ID: 12737669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Coasting: a response to excessive ovarian stimulation].
    Dechaud H; Anahory T; Aligier N; Arnal F; Humeau C; Hédon B
    Gynecol Obstet Fertil; 2000 Feb; 28(2):115-9. PubMed ID: 10758585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [HMG-HCG therapy for ovarian hyperstimulation syndrome].
    Ishimaru T; Okamoto J; Morizaki M; Kajimura H; Nakano T
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Jun; 36(6):969-72. PubMed ID: 6431038
    [No Abstract]   [Full Text] [Related]  

  • 17. A gonadotropin releasing hormone agonist trigger of ovulation with aggressive luteal phase support for patients at risk of ovarian hyperstimulation syndrome undergoing controlled ovarian hyperstimulation.
    Liang IT; Huang HY; Wu HM; Wang HS; Yu HT; Huang SY; Chang CL; Soong YK
    Taiwan J Obstet Gynecol; 2015 Oct; 54(5):583-7. PubMed ID: 26522115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Quintuplet pregnancy with a positive outcome induced by a minimum dosage of HMG + HCG].
    Garcea N; Sgreccia M
    Minerva Ginecol; 1984 Jun; 36(6):299-302. PubMed ID: 6433241
    [No Abstract]   [Full Text] [Related]  

  • 19. Severe ovarian hyperstimulation syndrome despite low plasma oestrogen concentrations in a hypogonadotrophic, hypogonadal patient.
    Levy T; Orvieto R; Homburg R; Peleg D; Dekel A; Ben-Rafael Z
    Hum Reprod; 1996 Jun; 11(6):1177-9. PubMed ID: 8671418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preventing severe ovarian hyperstimulation syndrome in an in vitro fertilization/embryo transfer program. Use of follicular aspiration after human chorionic gonadotropin administration.
    Vrtovec HM; Tomazevic T
    J Reprod Med; 1995 Jan; 40(1):37-40. PubMed ID: 7722973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.